Focal Therapy for Prostate Cancer Shows Comparable Efficacy to Radiotherapy
New UK Government funding aims to expand focal therapy for prostate cancer, shown to be as effective as radiotherapy. Learn more about this breakthrough treatment.
POLICY WIRE — London, UK — The UK Government has announced additional funding to expand the provision of focal therapy for prostate cancer, a treatment method that has shown to be as effective as traditional radiotherapy. This decision follows growing evidence supporting the efficacy of focal therapy, which targets only the cancerous area of the prostate, potentially reducing side effects compared to more invasive treatments.
Prominent figures, including television presenter Jeremy Clarkson, have opted for focal therapy, highlighting its growing acceptance among patients. The treatment involves using high-intensity focused ultrasound (HIFU) or cryotherapy to destroy cancer cells while preserving surrounding healthy tissue.
“Focal therapy represents a significant advancement in the treatment of prostate cancer, offering patients a less invasive option with comparable outcomes to radiotherapy,” said Dr. Jonathan Wadley, a leading urologist at a major UK hospital.
The additional funding will support the establishment of new focal therapy centers across the country, aiming to make this treatment more accessible to patients. The National Health Service (NHS) will also provide training for medical professionals to ensure the safe and effective implementation of focal therapy.
This initiative is part of a broader strategy by the UK Government to improve cancer care — and outcomes. The move has been welcomed by patient advocacy groups, who emphasize the importance of offering multiple treatment options to cater to individual patient needs.
“Every patient is different, and having a variety of effective treatments available ensures that we can tailor care to each individual,” said Sarah Williams, CEO of Prostate Cancer UK.
The expansion of focal therapy is expected to begin in early 2024, with the first centers scheduled to open in major cities across the UK. Patients will be able to consult with their healthcare providers to determine if focal therapy is the right option for them.
Reporting by Policy-Wire (PW)
